Fox David Morton purchased $142 of MDWD
Fox David Morton purchased 10 shares of MediWound Ltd. (MDWD) at $14.23 on 2026-06-01.
How this was made
The 30-second read
Why it matters
The disclosure adds incremental sentiment information (director buying) but does not introduce new company fundamentals or forward-looking guidance.
Market read
This is a low-impact insider-buy signal with limited trading relevance absent other catalysts.
What to watch
No 10b5-1 plan was cited, but the disclosed size is tiny, so traders should weight it far less than upcoming clinical/data, financing, or partnership news.
Background
The filing is an SEC Form 4 insider transaction disclosure for MediWound Ltd. (MDWD).
Ticker impact
Director Fox David Morton filed an open-market purchase of 10 shares at $14.23 on 2026-06-01, increasing direct holdings to 20,486.
Low likelihood of a material, immediate price move from this specific Form 4 alone.
This is a disclosed insider transaction (Form 4) with a very small value ($142.30) and no accompanying corporate event (earnings, trial, deal, guidance).
Market effects
Minimal; this is company-specific insider activity with no stated sector/regulatory trigger.
None indicated.
None indicated.
Counterpoint
A small open-market buy can be routine (e.g., liquidity/plan mechanics) and may not reflect a new fundamental catalyst.
Key entities
- issuerMediWound Ltd.
Subject of the Form 4 insider transaction; director purchased shares on 2026-06-01.
- insiderFox David Morton
Director who reported an open-market purchase of 10 shares at $14.23.